Daphnia Labs
Organization Description
Daphnia Labs is developing a new platform for the discovery of geroprotective drugs: in vivo phenotypic screens in model organisms. The company uses high-resolution video to track Daphnia during its lifespan in order to screen for drugs that might extend healthspan.
As of 2021 the company website has expired and it appears the company has ceased to operate.
Team
Sarah Constantin, Ph.D.
Daphnia Labs
Related News
August 09, 2019
We recently had the opportunity to catch up with Sarah Constantin, one of the founders of the new biotech startup company Daphnia Labs. The company is developing a new platform for the discovery of geroprotective drugs: in vivo phenotypic screens in model organisms. The company plans to use high-resolution video to track Daphnia during its...